Meeting
2018 ASCO Annual Meeting
Mechanisms of immune evasion in triple-negative breast cancer patients.
Authors
Javier Ignacio Orozco
John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA
Javier Ignacio Orozco , Ayla O. Manughian-Peter , Matthew P. Salomon , Steven O'Day , Dave S. B. Hoon , Diego M. Marzese
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Triple-Negative
Citation
J Clin Oncol 36, 2018 (suppl; abstr 1096)
DOI
10.1200/JCO.2018.36.15_suppl.1096
Abstract #
1096
Poster Bd #
177
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
FGFR3 correlation with mutant p53 and its prognostic value in oropharyngeal squamous cell carcinoma (OPSCC).
First Author: Zhuo Georgia Chen
Poster
2016 Gastrointestinal Cancers Symposium
A new immunohistochemistry prognostic score (IPS) for recurrence and survival in pancreatic neuroendocrine tumors (PanNET).
First Author: Antonio Viudez
Poster
2013 ASCO Annual Meeting
Cancer-testis antigens in triple-negative and locally advanced breast cancer.
First Author: Samuel John Harris
Poster
2013 ASCO Annual Meeting
Effect of adding oxaliplatin to adjuvant 5-fluorouracil/leucovorin (5FU/LV) in patients with defective mismatch repair (dMMR) colon cancer stage II and III included in the MOSIAC study.
First Author: Jean-François Flejou